Trial Information
Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity. (KWF RUG 2004-3157)
Inclusion Criteria:
- Patients with non-seminomatous testicular cancer
- Have been uniformly treated with orchidectomy and cisplatin-bleomycin combination
chemotherapy at the University Hospital Groningen, The Netherlands, since 1977 but
before 01-01-2000 are eligible.
Exclusion Criteria:
- N/A
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Elisabeth G.E. de Vries, MD, PhD
Investigator Role:
Study Director
Investigator Affiliation:
University Medical Centre Groningen
Authority:
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study ID:
KWF RUG 2004-3157
NCT ID:
NCT00161174
Start Date:
July 2005
Completion Date:
December 2010
Related Keywords:
- Non-Seminomatous Testicular Cancer
- testicular cancer
- cardiovascular morbidity
- cardiovascular risk factors
- pharmacogenomic determinants
- Testicular Neoplasms